1282516-44-2

Basic information

• Product Name: IMidazo[1,2-d][1,4]benzoxazepine-10-carboxylic acid, 5,6-dihydro-2-iodo-, Methyl ester
• Synonyms: IMidazo[1,2-d][1,4]benzoxazepine-10-carboxylic acid, 5,6-dihydro-2-iodo-, Methyl ester;5,6-Dihydro-2-iodo-imidazo[1,2-d][1,4]benzoxazepine-10-carboxylic acid, methyl ester;Methyl 2-iodo-5,6-dihydrobenzo[f]iMidazo[1,2-d][1,4]oxazepine-10-carboxylate;Methyl 2-iodo-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine-10-carboxylate
• CAS NO: 1282516-44-2
• Molecular Formula: C₁₃H₁₁IN₂O₃
• Molecular Weight: 370.14251
• Mol File: 1282516-44-2.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: IMidazo[1,2-d][1,4]benzoxazepine-10-carboxylic acid, 5,6-dihydro-2-iodo-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: IMidazo[1,2-d][1,4]benzoxazepine-10-carboxylic acid, 5,6-dihydro-2-iodo-, Methyl ester(1282516-44-2)
• EPA Substance Registry System: IMidazo[1,2-d][1,4]benzoxazepine-10-carboxylic acid, 5,6-dihydro-2-iodo-, Methyl ester(1282516-44-2)

Safety Data

• Hazardous Substances Data: 1282516-44-2(Hazardous Substances Data)

Usage

Description

IMidazo[1,2-d][1,4]benzoxazepine-10-carboxylic acid, 5,6-dihydro-2-iodo-, Methyl ester is a heterocyclic compound that features both an imidazole and a benzoxazepine ring structure. This unique structure is further characterized by the presence of a carboxylic acid group at the 10th position and a methyl ester group. Additionally, it has a 5,6-dihydro-2-iodo substituent, which may contribute to its potential biological activities. Due to its distinctive chemical composition, this compound may hold promise in the fields of medicinal chemistry and pharmaceutical research.

Uses

Used in Medicinal Chemistry:
IMidazo[1,2-d][1,4]benzoxazepine-10-carboxylic acid, 5,6-dihydro-2-iodo-, Methyl ester is used as a compound of interest in medicinal chemistry for its potential to be developed into pharmaceutical agents. Its unique structure may allow for the design of new drugs targeting specific biological pathways or receptors.
Used in Pharmaceutical Research:
In pharmaceutical research, IMidazo[1,2-d][1,4]benzoxazepine-10-carboxylic acid, 5,6-dihydro-2-iodo-, Methyl ester is utilized as a starting point for the development of novel therapeutics. Its heterocyclic nature and functional groups may enable the creation of drugs with specific mechanisms of action or selectivity for particular diseases.
However, it is important to note that further studies are likely needed to fully understand the properties and potential uses of IMidazo[1,2-d][1,4]benzoxazepine-10-carboxylic acid, 5,6-dihydro-2-iodo-, Methyl ester. This will involve exploring its biological activities, pharmacokinetics, and safety profile to determine its suitability as a pharmaceutical agent.

Downstream Products

• 1282517-30-9 2-(1-(2-chlorophenyl)-1H-imidazol-2-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-10-carboxylic acid 
• 1282517-31-0 methyl 2-(1-(2-chlorophenyl)-1H-imidazol-2-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-10-carboxylate 

Relevant articles and documents

BENZOXAZEPIN COMPOUNDS SELECTIVE FOR PI3K P110 DELTA AND METHODS OF USE

Benzoxazepin Formula I compounds, including stereoisomers, geometric isomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting the delta isoform of PI3K, and for treating disorders mediated by lipid kinases such as inflammation, immunological disorders, and cancer. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.